Mesoblast Financial Overview
Mesoblast's market cap is currently $2.37B. The company's EPS TTM is $-0.43; its P/E ratio is -21.99; Mesoblast is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
